The startup develops preservation solutions for the organ procurement and transplant sector, utilizing a formulation identical to histidine tryptophan ketoglutarate for organ flushing, perfusion, and storage. This technology extends the viability of procured organs, ensuring they remain suitable for transplantation until needed.
Funding
$430K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The viability of organs procured for transplantation is time-sensitive, and inadequate preservation can lead to organ damage and render them unsuitable for transplant. Current preservation methods may not always provide optimal conditions for maintaining organ function and integrity during storage and transport.
Solution
Global Transplant Solutions (GTS) provides a range of sterile, pyrogen-free organ preservation solutions designed to optimize organ viability from procurement to transplantation. Their Servator® line of products includes solutions for flushing, perfusion, and cold storage of various organs, such as kidneys, livers, pancreases, hearts, and lungs. These solutions are manufactured under rigorous quality control standards and are FDA-cleared to meet the specific needs of organ procurement organizations and transplant centers. GTS's preservation solutions aim to extend the window of opportunity for successful transplantation, ultimately increasing the number of viable organs available for patients in need.
Target Audience
The primary target audience includes organ procurement organizations (OPOs), transplant centers, and hospitals involved in organ transplantation.
Features
- Servator® B: Preservation solution for kidneys, livers, and pancreas
- Servator® H: Flushing and preservation solution for various organs
- Servator® C: Solution for flushing and cold storage of cardiac allografts
- Servator® P: Colloid-based electrolyte preservation solution for lungs
- Servator® M: Solution for in-vitro flushing and machine perfusion of kidneys
- Products meet quality standards set by the US FDA, the European Union Health Ministry, and Health Canada
- Thermal protective shipping containers to maintain controlled temperatures during transport
- Intensive inspection process to ensure product quality and control